(NU/1824) The Provision of Clinical Research Support & Central Laboratory Services for the ADVANCE Study

The procurement contact named on the official notice.

The Newcastle University Translational and Clinical Research Institute is one of three research institutes established in 2019 following a restructure within the Faculty of Medical Sciences.

Its members map across the biomedical research landscape.

A number of major research projects are led from within the Institute including the “NASH Disease Translational Accelerator” (NASH-DTA) project.

This project funded brings together clinicians and scientists from prominent academic centres across Europe and industrial partners to conduct research into advanced liver disease/cirrhosis caused by non-alcoholic fatty liver disease (NAFLD).

Their common goals are developing, validating and qualifying better biomarkers for NAFLD.

Strongly associated with the epidemics of obesity and type 2 diabetes that are testing healthcare systems worldwide, NAFLD is an increasingly common cause of advanced liver disease that is characterized by substantial inter-patient variability in severity and rate of progression.

Biomarkers under investigation in the project include genes that contribute to NAFLD progression.

The purpose of this tender process is to engage a supplier to provide clinical research support, central laboratory services and to oversee biological sample transfers and provide centralised laboratory processing of biological samples collected during the course of the study.